News
-
-
-
PRESS RELEASE
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide -
-
-
-
-
-
-
PRESS RELEASE
EPG Completes Nearly US$100 Million Series B Financing, Bolsters Global Data Center Delivery Capabilities
EPG completes nearly US$100 million Series B financing to bolster global data center delivery capabilities. The round was co-led by international investment firms Forebright and Silicon Peak